OakChart

Seer Inc

SEERHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 3:57 PM ET

1.59-0.02 (-1.24%)
2026-11-12 00:38 CET
Market cap
89.15 USD m
Revenue, TTM
13.95 USD m
Net income, TTM
-63.47 USD m
Free cash flow, TTM
-46.35 USD m
EPS diluted, TTM
-1.14
P/E
-
Compare

Price

SEER against its 20, 50 and 200-day averages
2050200missearnings
1.601.802.002.202.4014.6M29.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SEERclose 1.5920-day 1.8450-day 1.95200-day 1.911.5952w high52w low

33.1% under the 52-week high of 2.38 on 5 Oct 2026. 52-week low 1.55 on 2 Jul 2026. Last 15 sessions, 33.3% high to low

Volume 1.14× normal · the line is the 50-bar volume average

Profile

SEER
52-week range, 5% of the way up
1.552.38

Seer, Inc. engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite consists of automation instruments and software, which provide a workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.

Employees124
IPODec 04, 2020
Beta1.45
ATR, 14d0.11
Rel volume1.14
Short float0.22%
Insider own33.39%
Inst own28.42%

Snapshot

6 groups

Valuation

Index-
Market Cap88.04M
Enterprise Value-46.12M
Income-63.47M
Sales13.95M
Book/sh3.81
Cash/sh2.82
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees124
IPODec 04, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S6.31
P/B0.42
P/C0.56
P/FCF-
EV/EBITDA-
EV/Sales-3.31
Quick Ratio16.24
Current Ratio16.89
Debt/Eq0.10
LT Debt/Eq0.09
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.14
EPS next Y-0.96
EPS next Q-0.22
EPS this Y15.52%
EPS next Y11.55%
EPS next 5Y15.04%
EPS past 3/5Y4.89% -18.95%
Sales past 3/5Y3.15% 89.71%
EPS Y/Y TTM12.29%
Sales Y/Y TTM-14.56%
EPS Q/Q23.63%
Sales Q/Q-3.40%
EarningsNov 10 AMC
EPS/Sales Surpr.3.85% -4.07%

Ownership

Insider Own33.39%
Insider Trans-0.14%
Inst Own28.42%
Inst Trans5.37%
ROA-23.06%
ROE-26.19%
ROIC-27.37%
Gross Margin46.04%
Oper. Margin-475.14%
Profit Margin-455.00%
SMA20-13.68%
SMA50-18.51%
SMA200-16.79%
Trades-

Technical

Shs Outstand55.81M
Shs Float36.88M
Short Float0.22%
Short Ratio0.36
Short Interest0.08M
52W High2.38 -33.05%
52W Low1.55 2.58%
Volatility6.71% 5.71%
ATR (14)0.11
RSI (14)28.87
Beta1.45
Rel Volume1.14
Avg Volume227.84K
Volume260,811

Performance

Perf Week-6.47%
Perf Month-24.64%
Perf Quarter-24.29%
Perf Half Y-10.17%
Perf YTD-13.11%
Perf Year-23.19%
Perf 3Y1.92%
Perf 5Y-94.58%
Perf 10Y-
Recom1.00
Target Price4.00
Prev Close1.61
Price1.59
Change %-1.24%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
May 04, 2026InitiatedCCanaccord GenuityBuy$4+151.6%
Jul 05, 2023ResumedJJP MorganNeutral$10+528.9%
Jan 04, 2023DowngradeBBofA SecuritiesNeutral → Underperform$9 → $6.50+308.8%
Aug 11, 2022DowngradeJJP MorganOverweight → Neutral$20 → $12+654.7%
Oct 15, 2021ResumedCCowenOutperform
Dec 29, 2020InitiatedMMorgan StanleyEqual-Weight$65+3,988.1%
Dec 29, 2020InitiatedJJP MorganOverweight$75+4,617.0%
Dec 29, 2020InitiatedCCowenOutperform
Dec 29, 2020InitiatedBBofA SecuritiesNeutral$69+4,239.6%

Peers

Mkt cap
TickerCompanyMkt cap
NAUTNautilus Biotechnology Inc308.24M
QSIQuantum-Si Incorporated279.07M
QTRXQuanterix Corp143.39M
LABStandard BioTools Inc253.85M
TECHBio-Techne Corp11.44B
BRKRBruker Corp9.53B
TXG10x Genomics Inc8.08B
PACBPacific Biosciences of California Inc654.02M
TMOThermo Fisher Scientific Inc265.92B
BNGOBionano Genomics Inc15.37M

Insider trading

8 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Horn David R.PRESIDENT & CFOAug 18 '26Sale2.037,30914,809486,650Aug 19 06:59 PM
Nishar DipchandDirectorJul 08 '26Sale2.1810,66023,26559,044Jul 10 06:23 PM
DIPCHAND NISHARDirectorJul 08 '26Proposed Sale2.1810,66023,265Jul 08 04:03 PM
Horn David R.PRESIDENT & CFOMay 20 '26Sale1.697,30312,352493,959May 21 05:12 PM
Horn David R.PRESIDENT & CFOFeb 18 '26Sale1.997,74315,447501,262Feb 19 04:11 PM
Farokhzad OmidCEO AND CHAIRFeb 18 '26Sale1.9924,38548,6463,349,064Feb 19 04:06 PM
Horn David R.PRESIDENT & CFONov 19 '25Sale1.976,79713,400436,802Nov 21 05:31 PM
Farokhzad OmidCEO AND CHAIRNov 19 '25Sale1.9733,83866,7081,238,230Nov 21 05:29 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
AVUSAvantis U.S. Equity ETFAUM: 14.65B

News

latest 14 of 200
  • Seer Narrows Its Loss Through Cost Cuts, But A 20% Guidance Reset Undercuts The Revenue Rebound (Earnings Whispers)
  • Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance (GlobeNewswire)
  • Seer Secures Key Victory in ITC Patent Dispute as Investigative Staff Backs All Requested Remedies Against Nanomics (GlobeNewswire)
  • Radoff-JEC Group Issues Open Letter Condemning Seer's Unexplained and Seemingly Illogical Decision to Remain a Public Company (Business Wire)
  • Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process (GlobeNewswire) -13.40%
  • Seer to Report Third Quarter 2026 Financial Results on November 10, 2026 (GlobeNewswire)
  • Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026 (GlobeNewswire)
  • Seer Announces CFO Transition (GlobeNewswire)
  • Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale (GlobeNewswire)
  • Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.s Board of Directors (Business Wire)
  • Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers (Business Wire)
  • Seer Inc (SEER) (Q2 2026) Earnings Call Highlights: Navigating Funding Headwinds While ... (GuruFocus.com)
  • Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook (GlobeNewswire)
  • Earnings To Watch: Seer Inc (SEER) Q2 2026 -- GF Value Sees 31% Upside (GuruFocus.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.250-0.260-0.2473.984.152
2026Q22026-08-11-0.310-0.270-0.3063.103.552
2026Q12026-05-13-0.300-0.295-0.3012.793.602
2025Q42026-02-26-0.290-0.320-0.2864.204.601
2025Q32025-11-06-0.320-0.300-0.3244.124.001
2025Q22025-08-06-0.330-0.372-0.3344.053.752
2025Q12025-05-13-0.340-0.362-0.3364.213.253
2024Q42025-02-27-0.370-0.387-0.3684.003.953
2024Q32024-11-06-0.350-0.308-0.3494.033.153
2024Q22024-08-08-0.350-0.360-0.3543.103.203
2024Q12024-05-08-0.320-0.300-0.3203.103.803
2023Q42024-02-29-0.280-0.371-0.2774.444.053
2023Q32023-11-07-0.330-0.400-0.3304.164.303
2023Q22023-08-08-0.370-0.396-0.3684.015.154
2023Q12023-05-09-0.380-0.383-0.3774.053.924
2022Q42023-03-02-0.360-0.427-0.3594.604.204

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-1.555-0.855-0.5380.670.66
2021FY-1.170-1.509-1.1696.625.65
2022FY-1.490-1.566-1.48915.5015.30
2023FY-1.350-1.449-1.35116.6616.72
2024FY-1.390-1.403-1.38914.1714.12
2025FY-1.280-1.310-1.38916.5817.00
2026FY--1.081--15.12
2027FY--0.957--18.83
2028FY--0.785--23.70
2029FY--0.665--30.20
2030FY--0.320--47.50

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-112015.104.205.99
2026Q4S2026-11-102006.105.996.20
2026Q4S2026-10-262006.105.996.20
2026Q4S2026-10-162206.105.996.20
2026Q4S2026-08-132206.106.006.20
2026Q4S2026-08-122206.105.996.20
2026Q4S2026-07-282005.475.335.60
2026Q4S2026-05-142205.475.335.60
2026Q4S2026-05-132005.155.105.20
2026Q4S2026-05-012015.155.105.20
2026Q4S2026-02-271015.205.205.20
2026Q4S2026-01-211006.606.606.60
2026Q4S2025-11-111016.606.606.60
2026Q4S2025-11-101016.606.606.60

Estimate history

EPS, annual-0.104-0.263-0.538-1.169-1.489-1.351-1.389-1.281-1.1398
Period20182019202020212022202320242025TTM
EPS, quarterly-0.349-0.368-0.336-0.334-0.324-0.286-0.301-0.306-0.247
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00.1160.6566.39414.68515.18213.94716.11913.95
Period20182019202020212022202320242025TTM
Sales, quarterly4.0323.9494.2054.0514.1214.0732.7933.1023.981
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual60.91160.91160.91162.01563.41164.29959.12856.2255.81
Period20182019202020212022202320242025MRQ
Shares, quarterly59.58559.12859.4356.32955.78656.2255.06655.355.81
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue13.9516.1213.9515.1814.696.390.660.120.00
Cost of Goods Sold Incl. D&A7.5314.2213.2913.7314.306.771.610.700.10
Gross Profit6.421.900.661.450.38-0.37-0.95-0.58-0.10
Selling, General and Administrative Excl. Other72.7080.35100.98106.3998.4371.3232.7016.306.66
Research and Development33.2037.7744.4147.4445.8029.1217.3411.693.68
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-66.28-78.45-100.32-104.94-98.04-71.70-33.65-16.88-6.76
Interest Expense0.000.000.000.000.000.000.000.010.00
Unusual Expense0.000.000.000.000.000.000.000.000.00
Net Income Before Taxes-63.42-73.40-86.50-86.28-92.97-71.17-32.77-16.04-6.31
Income Taxes0.050.200.100.000.000.000.000.000.00
Consolidated Net Income-63.47-73.60-86.60-86.28-92.97-71.17-32.77-16.04-6.31
Net Income From Continuing Operations-63.47-73.60-86.60-86.28-92.97-71.17-32.77-16.04-6.31
Net Income-63.47-73.60-86.60-86.28-92.97-71.17-32.77-16.04-6.31
EPS (Recurring)-1.14-1.28-1.39-1.35-1.49-1.17-0.54-0.26-0.10
EPS (Basic, Before Extraordinaries)-1.14-1.28-1.39-1.35-1.49-1.17-0.54-0.26-0.10
EPS (Diluted)-1.14-1.28-1.39-1.35-1.49-1.17-0.54-0.26-0.10
EBITDA-60.36-72.35-94.15-99.36-92.14-68.13-32.04-16.18-6.66
Non-Operating Income (Expense)2.865.0513.8218.665.080.530.870.850.45
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.4712.1822.2834.4233.6725.937.351.560.67
Price To Sales Ratio8.886.5210.338.1624.66217.135,212.72--
Gross Margin46.0411.804.709.542.61-5.85-144.82-504.31-
Operating Margin-475.14-486.70-719.32-691.23-667.64-1,121.30-5,129.42-14,554.31-
Net Margin-455.00-456.60-620.91-568.28-633.07-1,113.06-4,996.19-13,825.86-
Shares Outstanding55.8156.2259.1364.3063.4162.0260.9160.9160.91
Market Capitalization89.1589.15136.21123.82363.321,401.773,332.843,354.80-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3.983.102.794.074.124.054.213.95
Cost of Goods Sold Incl. D&A2.101.601.812.022.011.942.143.58
Gross Profit1.881.510.982.062.112.112.060.37
Selling, General and Administrative Excl. Other16.5518.3518.2419.5721.4622.6422.7923.91
Research and Development6.448.218.819.7410.8011.9811.3511.01
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-14.67-16.84-17.26-17.51-19.35-20.53-20.73-23.54
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-13.73-16.89-16.83-15.97-18.21-19.38-19.85-21.64
Income Taxes0.010.010.010.030.020.050.100.10
Consolidated Net Income-13.74-16.90-16.84-15.99-18.23-19.42-19.95-21.74
Net Income From Continuing Operations-13.74-16.90-16.84-15.99-18.23-19.42-19.95-21.74
Net Income-13.74-16.90-16.84-15.99-18.23-19.42-19.95-21.74
EPS (Recurring)-0.25-0.31-0.30-0.29-0.32-0.33-0.34-0.37
EPS (Basic, Before Extraordinaries)-0.25-0.31-0.30-0.29-0.32-0.33-0.34-0.37
EPS (Diluted)-0.25-0.31-0.30-0.29-0.32-0.33-0.34-0.37
EBITDA-13.27-15.35-15.73-16.01-17.89-18.99-19.13-21.93
Non-Operating Income (Expense)0.93-0.050.431.551.141.150.881.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.961.241.682.602.843.063.685.09
Price To Sales Ratio8.886.506.266.237.487.666.589.67
Gross Margin47.2048.5535.1650.4551.2052.1149.019.27
Operating Margin-368.43-542.91-617.83-429.98-469.45-506.79-493.01-596.07
Net Margin-345.09-544.78-602.83-392.68-442.47-479.49-474.39-550.57
Shares Outstanding55.8155.3055.0756.2255.7956.3359.4359.13
Market Capitalization89.1591.8294.79102.09122.26125.93101.03136.21

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments185.90236.41316.22421.24400.07431.8686.0230.95
Short Term Receivables5.956.236.727.024.140.260.330.07
Inventories7.797.444.494.634.140.550.000.00
Other Current Assets1.893.253.082.103.340.450.460.19
Total Current Assets201.53253.32330.51434.98411.70433.1386.8131.21
Net Property, Plant & Equipment35.2441.3747.3746.4133.238.445.692.36
Total Investments and Advances55.2163.6357.385.6893.710.340.340.00
Other Assets4.108.281.000.850.500.410.400.12
Total Assets296.08366.60436.27487.93539.14442.3293.2433.70
Short Term Debt Incl. Current Port. of LT Debt2.582.312.291.840.860.000.000.00
Accounts Payable5.614.621.372.103.792.120.702.62
Income Tax Payable0.640.470.500.340.46---
Other Current Liabilities6.877.929.068.308.315.983.111.07
Total Current Liabilities15.6915.3313.2212.5813.428.093.813.69
Long Term Debt21.0823.6525.9628.0322.460.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities0.010.050.180.320.342.621.740.03
Total Liabilities36.7839.0339.3740.9436.2210.715.563.72
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00107.9535.81
Common Equity259.31327.57396.90446.99502.92431.61-20.27-5.84
Total Shareholders Equity259.31327.57396.90446.99502.92431.6187.6829.98
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity259.31327.57396.90446.99502.92431.6187.6829.98
Total Liabilities & Stockholders Equity296.08366.60436.27487.93539.14442.3293.2433.70
Book Value Per Share4.615.546.177.058.117.09-0.33-0.10
Tangible Book Value Per Share4.615.546.177.058.117.09-0.33-0.10
Full-Time Employees12413414716411860--
Price to Book Ratio0.390.400.310.792.817.92-169.78-
Return on Assets-22.21-21.57-18.67-18.10-14.50-12.24-25.27-
Return on Equity-25.08-23.91-20.45-19.57-15.23-12.62-27.26-
Return on Invested Capital-26.25-24.66-20.40-19.57-13.55-7.59-18.29-21.04
Quick Ratio12.3516.0424.6634.2030.3653.4422.758.46
Current Ratio12.8416.5325.0034.5730.6753.5122.758.46

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-63.47-73.60-86.60-86.28-92.97-71.17-32.77-16.04-6.31
Depreciation5.926.106.185.585.903.561.610.700.03
Other Funds (Non Cash)14.8323.6334.4624.3633.6827.127.621.300.67
Funds from Operations-42.72-43.87-45.97-56.34-53.39-40.48-23.55-14.03-5.60
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-2.63-0.58-0.14-2.72-7.39-5.872.720.960.95
Cash from Operating Activities-45.34-44.45-46.11-59.06-60.78-46.35-20.83-13.07-4.65
Capital Expenditures-1.01-1.80-3.58-7.31-10.27-6.92-4.53-4.13-0.17
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.400.650.340.000.170.000.000.000.00
Purchase or Sale of Investments32.8362.7069.1045.21-112.62-163.96-30.02-68.250.00
Purchase of Investments-145.28-175.12-272.93-403.09-366.27-279.96-87.77-92.000.00
Sale Or Maturity of Investments178.11237.81342.02448.31253.65116.0057.7523.750.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities32.2361.5565.8637.90-122.72-170.88-34.56-72.38-0.17
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-2.54-9.74-11.490.453.89105.23371.4971.9329.95
Repurchase of Common Pref Stock-3.12-10.20-11.82-0.01-0.02-0.04-0.01-0.010.00
Sale of Common Pref Stock0.580.460.320.473.91105.27371.5071.9429.95
Proceedsfrom Stock Options0.400.400.320.370.78103.38370.2371.9329.95
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.400.00
Change in Long Term Debt0.000.000.000.000.000.000.000.400.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.400.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.00-0.830.000.000.0011.400.000.000.00
Other Financing Activities Uses0.00-0.830.000.000.000.000.000.000.00
Cash from Financing Activities-2.54-10.57-11.490.453.89116.63371.4972.3329.95
Net Change in Cash-15.666.538.25-20.71-179.60-100.59316.10-13.1225.13
Free Cash Flow-46.35-46.24-49.69-66.37-71.05-53.27-25.36-17.20-4.82
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00--
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments155.90152.85166.67185.90199.24209.83
Short Term Receivables3.833.434.265.955.165.71
Inventories6.407.668.087.798.137.51
Other Current Assets1.782.152.591.891.842.59
Total Current Assets167.90166.10181.59201.53214.36225.64
Net Property, Plant & Equipment29.6931.4633.3835.2436.5538.15
Total Investments and Advances42.7158.1656.4755.2152.4753.95
Other Assets1.490.930.694.105.224.75
Total Assets241.80256.64272.13296.08308.61322.49
Short Term Debt Incl. Current Port. of LT Debt2.792.712.642.582.512.44
Accounts Payable2.583.162.505.614.262.67
Income Tax Payable0.170.180.770.640.210.30
Other Current Liabilities4.405.224.336.878.066.37
Total Current Liabilities9.9411.2710.2415.6915.0411.79
Long Term Debt18.9619.6820.3821.0821.7422.39
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.010.010.030.010.010.02
Total Liabilities28.9130.9630.6536.7836.7934.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity212.89225.68241.48259.31271.81288.29
Total Shareholders Equity212.89225.68241.48259.31271.81288.29
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity212.89225.68241.48259.31271.81288.29
Total Liabilities & Stockholders Equity241.80256.64272.13296.08308.61322.49
Book Value Per Share3.814.084.394.614.875.12
Tangible Book Value Per Share3.814.084.394.614.875.12
Full-Time Employees---124--
Price to Book Ratio0.390.380.360.380.420.41
Return on Assets-23.06-23.47-22.76-22.21-22.93-22.61
Return on Equity-26.19-26.45-25.52-25.08-25.74-25.25
Return on Invested Capital-5.93-6.89-6.43-5.70-6.21-6.25
Quick Ratio16.2414.0616.9412.3513.7118.51
Current Ratio16.8914.7417.7312.8414.2519.15

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-13.74-16.90-16.84-15.99-18.23-19.42
Depreciation1.391.491.531.511.461.54
Other Funds (Non Cash)2.763.344.614.135.835.55
Funds from Operations-9.58-12.07-10.70-10.36-10.95-12.33
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.052.50-4.73-0.453.38-2.33
Cash from Operating Activities-9.53-9.57-15.44-10.81-7.57-14.66
Capital Expenditures-0.44-0.01-0.27-0.29-0.28-0.57
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.390.010.000.000.240.11
Purchase or Sale of Investments12.69-11.4718.3513.2716.647.82
Purchase of Investments-38.20-29.80-49.91-27.36-47.58-37.51
Sale Or Maturity of Investments50.8918.3368.2640.6364.2245.34
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities12.64-11.4718.0812.9816.607.36
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.13-0.20-2.610.14-1.99-7.22
Repurchase of Common Pref Stock-0.10-0.34-2.62-0.06-2.01-7.45
Sale of Common Pref Stock0.230.140.010.200.020.23
Proceedsfrom Stock Options0.000.000.000.400.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.13-0.20-2.610.14-1.99-7.22
Net Change in Cash3.24-21.240.032.317.04-14.51
Free Cash Flow-9.97-9.58-15.71-11.10-7.85-15.23

Revenue breakdown

Other2024: 223.00K 2025: 459.00K
Product2024: 10.99M 2025: 11.97M
Service2024: 2.96M 2025: 4.15M
United States2024: 14.17M 2025: 16.58M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.22%0.1M36.9M282.00K
2026-10-150.26%0.1M36.9M465.00K
2026-09-300.29%0.1M37.0M1.10M
2026-09-150.24%0.1M37.0M1.07M
2026-08-310.39%0.1M36.9M1.05M
2026-08-140.33%0.1M36.9M1.09M
2026-07-310.49%0.2M36.9M1.10M
2026-07-150.40%0.1M37.1M926.44K
2026-06-300.36%0.1M36.2M324.45K
2026-06-150.61%0.2M31.2M324.36K
2026-05-290.93%0.3M31.7M365.48K
2026-05-151.43%0.5M31.7M395.10K
2026-04-301.31%0.4M32.7M384.40K
2026-04-151.47%0.4M29.4M332.37K
2026-03-312.64%0.7M27.7M268.34K
2026-03-132.80%0.8M27.7M276.79K
2026-02-273.27%0.9M27.7M241.08K
2026-02-132.30%0.6M27.6M198.89K
2026-01-300.99%0.3M28.4M158.88K
2026-01-150.90%0.3M28.4M154.71K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.050.052.5561,6310.000.174-0.0090.001
call5.000.001.000.004.7120.000.000.116-0.0130.000
call7.500.000.100.005.7890.000.000.102-0.0140.000
put2.500.004.900.000.0000.000.00-0.826-0.0090.001
put5.001.055.900.000.0000.000.00-0.885-0.0120.001
put7.503.508.500.000.0000.000.00-0.898-0.0140.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02SCHEDULE 13DSEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-083Initial statement of beneficial ownership of securities2026-10-01SEC
2026-09-188-KCurrent report2026-09-14SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-07-318-KCurrent report2026-07-28SEC
2026-07-318-KCurrent report2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-28DFAN14ADefinitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material.SEC
2026-07-24DFAN14ADefinitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material.SEC
2026-07-22DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-07-22DFAN14ADefinitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material.SEC
2026-07-20DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-07-208-KCurrent report2026-07-20SEC
2026-07-20DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-07-20DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-07-17DFAN14ADefinitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material.SEC
2026-07-14DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-07-14DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080014.81K1
2026-070023.27K1
2026-060000
2026-050012.35K1
2026-040000
2026-030000
2026-020064.09K2
2026-010000
2025-120000
2025-110080.11K2

Institutional holders

Manager% owned
SOFTBANK GROUP CORP.9.28%
Siren, L.L.C.4.44%
BML Capital Management, LLC3.95%
ACADIAN ASSET MANAGEMENT LLC3.53%
VANGUARD CAPITAL MANAGEMENT LLC3.31%
BlackRock, Inc.2.58%
RENAISSANCE TECHNOLOGIES LLC1.78%
NANO CAP NEW MILLENNIUM GROWTH FUND L P1.49%
CITADEL ADVISORS LLC0.94%
TWO SIGMA INVESTMENTS, LP0.89%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.51%
Ultra-Small Company Fund0.69%
VANGUARD EXTENDED MARKET INDEX FUND0.68%
BlackRock Advantage Small Cap Core Fund0.55%
Fidelity Extended Market Index Fund0.51%
Goldman Sachs Absolute Return Tracker Fund0.29%
iShares Micro-Cap ETF0.28%
Fidelity Total Market Index Fund0.15%
Ultra-Small Company Market Fund0.12%
Fidelity Nasdaq Composite Index Fund0.12%

OakChart. SEER. Cached 15 minutes.